Pfizer Financials

Market Capitalization $149.84 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	35.25
Forward PE	9.02
Price to Sales TTM	$2.52
Price to Book MRQ	$1.62
Enterprise to Revenue	3.51
Enterprise to EBITDA	11.33

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	7.16%
Operating Margin	32.99%
Return on Assets TTM	3.31%
Return on Equity TTM	4.54%

Income Statement

Revenue TTM	$59,375,001,600
Revenue per Share TTM	$10.49
Quarterly Revenue Growth	31.20%
Gross Profit TTM	$41,430,999,040
EBITDA	$19,401,000,000
Net Income to Common TTM	$4,273,999,872
Diluted EPS TTM	$0.75
Quarterly Earnings Growth YoY	31.20%

Balance Sheet

Total Cash MRQ	$9,953,000,448
Total Cash per Share MRQ	$1.76
Total Debt MRQ	$
Total Debt to Equity MRQ	73.41
Current Ratio MRQ	1.00
Book Value per Share MRQ	$16.29

Cash Flow

Operating Cash Flow TTM	$11,262,999,552
Levered Free Cash Flow TTM	$11,420,749,824

PFE Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	5,666,990,080
Float Shares	5,659,396,268
Avg 10 Volume	34,637,740
Avg 30 Volume	None
Shares Short	75,709,116
Short Ratio	1.75
Short % of Shares	1.34%
% Held by Insiders	0.05%
% Held by Institutions	67.84%

Stock Price Summary

Beta	0.62
Fifty Two Week Low	$24.48
Fifty Two Week High	$31.54
Fifty Two Week Change	-5.33%
Day 50 MA	$26.07
Day 200 MA	$27.87

Dividends and Splits

Forward Annual Dividend Rate	$1.72
Forward Annual Dividend Yield	6.59%
Trailing Annual Dividend Rate	$1.69
Trailing Annual Dividend Yield	6.48%
Payout Ratio	222.67%
Dividend Date	2025-03-07
Ex Dividend Date	2025-01-24
Last Split Factor
Last Split Date	2020-11-17